CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK, REDEEMABLE COMMON STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]
Beginning balance, shares at Dec. 31, 2022		121,667,250
Beginning balance at Dec. 31, 2022	$ 74,051	$ 122	$ 450,786	$ (119)	$ (376,738)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of restricted stock units (in shares)		540,238
Vesting of restricted stock units	0
Stock-based compensation expense	1,645		1,645
Net income	(24,020)				(24,020)
Ending balance, shares at Mar. 31, 2023		122,207,488
Ending balance at Mar. 31, 2023	51,676	$ 122	452,431	(119)	(400,758)
Beginning balance, shares at Dec. 31, 2022		121,667,250
Beginning balance at Dec. 31, 2022	74,051	$ 122	450,786	(119)	(376,738)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	(82,037)
Ending balance, shares at Sep. 30, 2023		164,705,712
Ending balance at Sep. 30, 2023	67,594	$ 165	526,323	(119)	(458,775)
Beginning balance, shares at Mar. 31, 2023		122,207,488
Beginning balance at Mar. 31, 2023	51,676	$ 122	452,431	(119)	(400,758)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock and prefunded warrants in private placement equity transaction, net of issuance costs (in shares)		34,521,046
Issuance of common stock and prefunded warrants in private placement equity transaction, net of issuance costs	60,443	$ 35	60,408
Issuance of shares of common stock under employee stock purchase plan (in shares)		114,577
Issuance of shares of common stock under employee stock purchase plan	175		175
Exercise of stock and warrants (in shares)		7,476,345
Exercise of stock and warrants	8,811	$ 7	8,804
Vesting of restricted stock units (in shares)		98,555
Vesting of restricted stock units	0
Stock-based compensation expense	2,142		2,142
Net income	(55,712)				(55,712)
Ending balance, shares at Jun. 30, 2023		164,418,011
Ending balance at Jun. 30, 2023	67,535	$ 164	523,960	(119)	(456,470)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock and warrants (in shares)		1,500
Vesting of restricted stock units (in shares)		286,201
Vesting of restricted stock units	1
Reclassifications of Temporary to Permanent Equity	2		2
Stock-based compensation expense	2,361		2,361
Net income	(2,305)				(2,305)
Ending balance, shares at Sep. 30, 2023		164,705,712
Ending balance at Sep. 30, 2023	67,594	$ 165	526,323	(119)	(458,775)
Beginning balance, shares at Dec. 31, 2023		167,434,595
Beginning balance at Dec. 31, 2023	51,099	$ 167	528,956	(119)	(477,905)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock and warrants	0		(1)
Vesting of restricted stock units (in shares)		503,186
Vesting of restricted stock units		$ 1
Stock-based compensation expense	1,739		1,739
Unrealized loss on marketable securities	(36)			(36)
Net income	(51,766)				(51,766)
Ending balance, shares at Mar. 31, 2024		167,937,781
Ending balance at Mar. 31, 2024	1,036	$ 168	530,694	(155)	(529,671)
Beginning balance, shares at Dec. 31, 2023		167,434,595
Beginning balance at Dec. 31, 2023	51,099	$ 167	528,956	(119)	(477,905)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	2,371
Ending balance, shares at Sep. 30, 2024		168,511,264
Ending balance at Sep. 30, 2024	59,621	$ 168	535,101	(114)	(475,534)
Beginning balance, shares at Mar. 31, 2024		167,937,781
Beginning balance at Mar. 31, 2024	1,036	$ 168	530,694	(155)	(529,671)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of shares of common stock under employee stock purchase plan (in shares)		235,068
Issuance of shares of common stock under employee stock purchase plan	158		158
Exercise of stock and warrants	0
Vesting of restricted stock units (in shares)		23,331
Stock-based compensation expense	2,428		2,428
Unrealized loss on marketable securities	(4)			(4)
Net income	90,833				90,833
Ending balance, shares at Jun. 30, 2024		168,196,180
Ending balance at Jun. 30, 2024	94,451	$ 168	533,280	(159)	(438,838)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock and warrants			1
Vesting of restricted stock units (in shares)		315,084
Vesting of restricted stock units	1
Stock-based compensation expense	1,820		1,820
Unrealized loss on marketable securities	45			45
Net income	(36,696)				(36,696)
Ending balance, shares at Sep. 30, 2024		168,511,264
Ending balance at Sep. 30, 2024	$ 59,621	$ 168	$ 535,101	$ (114)	$ (475,534)